MedPath

Single-center Study of Gustation in Idiopathic Parkinson's Disease and Lewy Body Disease Using Gustatory Evoked Potential Analysis

Not Applicable
Recruiting
Conditions
Idiopathic Parkinson's Disease and Lewy Body Disease
Interventions
Biological: Fasting blood test
Other: Subject interview
Other: Motor assessment
Other: Neurocognitive assessment
Other: Nutritional assessment
Other: Taste tests
Registration Number
NCT06439355
Lead Sponsor
Centre Hospitalier Universitaire Dijon
Brief Summary

The aim of the PI-PEG study is to explore the taste functions of the following 3 groups of participants:

* healthy volunteers

* patients with early Parkinson's disease

* patients with incipient Lewy body disease.

To this end, the results obtained from taste evoked potentials in each of the 3 groups of participants will be compared with each other and with different nutritional, motor and cognitive data.

This study could reveal a difference in cortical processing of gustatory sensory information between patients who have had idiopathic Parkinson's disease progressing for 3 years or less, and patients who have had Lewy body disease progressing for 3 years or less. Indeed, a modification of taste evoked potentials (in terms of latencies) proportional to the degree of cerebral degeneration could be observed.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
66
Inclusion Criteria

Healthy volunteers:

  • Person who has given written consent
  • Adult
  • Enrolled in the national register of healthy volunteers
  • Fasting > 2 hours before PEG measurement
  • Body Mass Index (BMI) < 30 kg/m².
  • No cognitive complaints and normal neurological assessment

Patients with idiopathic Parkinson's disease:

  • Person who has given written consent
  • Adult
  • Fasting > 2 hours before PEG measurement
  • Body Mass Index (BMI) < 30 kg/m².
  • Diagnostic criteria for established or probable IPD

Patients with Lewy body disease:

  • Person who has given written consent
  • Adult
  • Fasting > 2 hours prior to PEG measurement
  • Body Mass Index (BMI) < 30 kg/m².
  • Diagnostic criteria for probable or possible LBD
Read More
Exclusion Criteria
  • Non-affiliated to national health insurance
  • Person under legal protection (curatorship, guardianship)
  • Person subject to a court order
  • Pregnant, parturient or breast-feeding women
  • Major unable to give consent
  • MMSE score < 15 and/or MoCA < 10
  • Known infection with COVID-19 in the 6 months prior to inclusion
  • Active smoker (> 4 cigarettes per day on a regular basis)
  • Subject with pacemaker (contraindication for bioelectrical impedancemetry)
  • Diabetic (type 1 or type 2)
  • Taking medication (in progress at the time of the study) that interferes with gustation
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Patients with Lewy body disease (LBD) progressing ≤ 3 yearsTaste tests-
Healthy volunteersFasting blood test-
Healthy volunteersNutritional assessment-
Patients with Idiopathic Parkinson's Disease (IPD) of course ≤ 3 yearsMotor assessment-
Patients with Idiopathic Parkinson's Disease (IPD) of course ≤ 3 yearsTaste tests-
Patients with Lewy body disease (LBD) progressing ≤ 3 yearsNutritional assessment-
Healthy volunteersSubject interview-
Healthy volunteersMotor assessment-
Patients with Idiopathic Parkinson's Disease (IPD) of course ≤ 3 yearsFasting blood test-
Patients with Idiopathic Parkinson's Disease (IPD) of course ≤ 3 yearsNutritional assessment-
Patients with Lewy body disease (LBD) progressing ≤ 3 yearsNeurocognitive assessment-
Patients with Lewy body disease (LBD) progressing ≤ 3 yearsSubject interview-
Healthy volunteersNeurocognitive assessment-
Healthy volunteersTaste tests-
Patients with Idiopathic Parkinson's Disease (IPD) of course ≤ 3 yearsSubject interview-
Patients with Idiopathic Parkinson's Disease (IPD) of course ≤ 3 yearsNeurocognitive assessment-
Patients with Lewy body disease (LBD) progressing ≤ 3 yearsFasting blood test-
Patients with Lewy body disease (LBD) progressing ≤ 3 yearsMotor assessment-
Primary Outcome Measures
NameTimeMethod
Average latency of taste-evoked potentialsAfter a 2-hour fasting period
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Chu Dijon Bourgogne

🇫🇷

Dijon, France

© Copyright 2025. All Rights Reserved by MedPath